Fate Therapeutics(DE:F6T)
€1.56-0.12 (-7.15%)
DE:F6T
Fate Therapeutics earnings date
€1.56
At close:-0.12 (-7.15%)
Fate Therapeutics (F6T) Q2 2023 Earnings Report
1 Followers
DE:F6T Q2 2023 EPS Results
- Actual EPS
- -EUR 0.48
- Consensus EPS
- -EUR 0.53
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- -EUR 0.71
DE:F6T Q2 2023 Revenue Results
- Actual Revenue
- EUR 835.36K
- Expected Revenue
- EUR 4.84M
- Beat/Miss
- Missed by -EUR 4.01M
- YoY Revenue Growth
- -94.97%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- After Close
- Conference Call
- Tuesday, August 8, 2023
DE:F6T Upcoming Earnings
Fate Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:F6T Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:F6T Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.23- | -0.24 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.24-0.22 | -0.24 | 7.41% (+0.02) | |
| Aug 13, 2026 | 2026 (Q2) | -0.24-0.22 | -0.26 | 13.79% (+0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.25-0.23 | -0.29 | 18.75% (+0.05) | |
| Feb 26, 2026 | 2025 (Q4) | -0.24-0.24 | -0.39 | 38.64% (+0.15) | |
| Nov 13, 2025 | 2025 (Q3) | -0.26-0.24 | -0.36 | 32.50% (+0.12) | |
| Aug 12, 2025 | 2025 (Q2) | -0.31-0.26 | -0.3 | 12.12% (+0.04) | |
| May 13, 2025 | 2025 (Q1) | -0.34-0.29 | -0.42 | 31.91% (+0.13) | |
| Mar 05, 2025 | 2024 (Q4) | -0.39-0.39 | -0.4 | 2.22% (+0.01) | |
| Nov 12, 2024 | 2024 (Q3) | -0.37-0.36 | -0.41 | 13.04% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
